HairDx Opens European Subsidiary | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular dermatology company HairDx, a subsidiary of PharmaGenoma, has launched a Belgian subsidiary to market its hair loss predictive test products in Europe, the company said today.

PharmaGenoma said that the HairDx Europe subsidiary will offer throughout Europe its genetic test for Androgenetic Alopecia, which the company said is the most common cause of hair loss in both men and women. The company noted that it has recently struck distribution agreements for the HairDX test in Italy and Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.